| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO | Director +1 more
2 companies
Shenouda Maged is a Chief Financial Officer at RLMD, with reported holdings spanning 2 companies. Recent filings cover 19 purchases and 18 sales. Those positions are worth an estimated $4.3M at current prices.
Our model assigns Shenouda Maged a middling insider score of 52/100, based on 12 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -7.3%.
Shenouda Maged's largest disclosed position is in RLMD as Chief Financial Officer, worth about $4.3M. Net of sales, the recent Form 4 record there shows accumulation of 967,750 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2021 | RLMD Relmada Therapeutics, Inc. | CFO | Sale+OE | 3,200 | $35.04 | $112,133.92 | -59.0% | |
| Jan 27, 2021 | RLMD Relmada Therapeutics, Inc. | CFO | Sale+OE | 3,000 | $31.93 | $95,778.00 | -57.4% | |
| Jan 26, 2021 | RLMD Relmada Therapeutics, Inc. | CFO | Sale+OE | 4,000 | $35.40 | $141,611.71 | -64.2% | |
| Oct 21, 2019 | RLMD Relmada Therapeutics, Inc. | Director | Buy | 978 | $23.00 | $22,494.00 | +78.2% | |
| Dec 28, 2018 | GRDX Gridai Technologies Corp. | Chief Financial Officer | Buy | 20,000 | $1.31 | $26,214.00 | +47.1% | |
| Dec 15, 2015 | RLMD Relmada Therapeutics, Inc. | Director | Buy | 3,000 | $2.99 | $8,957.59 | +150.0% | |
| Dec 14, 2015 | RLMD Relmada Therapeutics, Inc. | Director | Buy | 2,000 | $2.89 | $5,780.00 | New |